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Hepatitis B virus infection in northern India
Prevalence, subtypes, and seasonal variation *
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& P. N. CHHUTITANI 6
Previous reports from India have been limited to the. incidences of hepatitis B antigen
(HB Ag) in health and disease. This paper reports on a study undertaken over the last
two years to determine the incidence of hepatitis B virus infection, the serotypes prevalent
among apparently healthy individuals and patients with liver diseases, and the seasonal
incidence of sporadic acute hepatitis in this geographic area. The incidences of infection in
health and disease show an endemic pattern. The Y subtype predominates among healthy car-
riers andpatients with chronic liver diseases, whereas theD subtypepredominates inpatients
with acute hepatitis. The similarity of subtypes of HB Ag among the majority of healthy
carriers and patients with chronic liver diseases suggests that the majority of asymp-
tomatic carriers (subclinically infected) would develop chronic liver disease. The proportion
of HB Ag-positive cases of acute hepatitis was significantly higher during the two summer
seasons than during the two winter seasons; this could be due to more frequent trans-
mission of the virus by the faecal/urinary-oral route and its activation during the summer
months, especially in areas with poor hygienic conditions. The urinary/faecal excretion
of virus could thus maintain the natural transmission of the virus in such an environment.
Hepatitis B virus infection is ubiquitous in nature.
The incidences of hepatitis B antigen (HB Ag) in
healthy persons and in those with liver diseases vary
considerably in different parts of the world (3-5, 8,
14, 22). Reports from India (6, 10, 15, 19) have
been limited to only the incidences of HB Ag in
health and disease.
Our study was undertaken during the period
March 1972-February 1974 to determine the inci-
dence of hepatitis B virus infection, the serotypes
prevalent among apparently healthy individuals and
patients with liver diseases, and the seasonal inci-
dence of sporadic acute hepatitis in northern India.
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MATERIALS AND METHODS
Control subjects
A total of 1 966 serum samples (Table 1) were
collected from apparently healthy, adult male volun-
tary blood donors, healthy women with or without
a previous pregnancy, children (aged 6 months-
14 years) attending the outpatient department for
minor ailments without any evidence of liver dis-
eases, newborn babies (sera from matched cord
blood), and patients with diseases not connected
with the liver who had a long stay in hospital.
Patients with liver diseases
A total of 383 serum samples (Table 1) were col-
lected from patients with liver diseases, who at-
tended the hospital from provincial areas of Punjab,
Haryana, and Himachal Pradesh; 265 of these serum
samples were obtained from sporadic cases of hepa-
titis.
3231 -13
14 S. R. PAL ET AL.
Table 1. Incidence of H B Ag among apparently healthy
individuals and patients with hepatic and nonhepatic
diseases in northern India
Total no. of No.Source of serum samples sera tested positive a
Control subjects:
adult male voluntary blood donors 1040 24 (2.3)
healthy adult females (previously preg-
nant & nonpregnant) 460 2 (0.43)
cord blood 88 0
all children (6 months-14 years): 238 3 (1.3)
6 months-4 years 109 0
5-9 years 56 2
1 0-14 years 73 1
hospitalized adult patients with nonhep-
atic diseases 140 2 (1.4)
Patients with liver diseases:
sporadic acute hepatitis 265 41 (15)
chronic liver diseases: 78 15 (19)
chronic aggressive hepatitis 5 3
postnecrotic cirrhosis 51 7 (14)
noncirrhotic portal fibrosis 15 2 (13)
malignancy in the liver 7 3
amoebic liver abscess 18 1
alcoholic liver disease 8 0
extrahepatic portal obstruction 14 1
a Figures in parentheses are percentages.
Immunoelectro-osmophoresis method (JEOP)
HB Ag was detected in undiluted serum samples
by the IEOP method (16). The gel consisted of
Noble Agar (Difco) (8.5 g/l) and a constant poten-
tial of 180 V (24 V/cm) was applied, which under
these conditions gave 3-4 mA/cm. Antisera, kindly
supplied by Professor F. G. Wewalka and Professor
S. Sherlock, were used in the detection of HB Ag
in the serum samples. The results were confirmed
against a reference guinea pig antiserum (V801-
501-058); a some of the positive sera were also con-
firmed by discontinuous immunoelectrophoresis (21)
with a reference caprine antiserum obtained from
a Obtained from the Research Reference Reagents
Branch, National Institute of Allergy and Infectious Dis-
eases, National Institutes of Health, Bethesda, Md., USA.
the World Health Organization, Geneva, in a re-
cently undertaken WHO collaborative study scheme.
Preparation of monospecific serum and typing of
HB Ag
Monospecific anti-d and anti-y sera were prepared
according to the method of Holland et al. (11) from
anti-ad guinea pig serum (V801-502-558) and anti-ay
guinea pig serum (V802-501-558), respectively, by the
use of cross absorption with HB Ag containing
the ay antigenic determinant (V-802-001-027) and
HB Ag containing the ad antigenic determinant
(V-801-001-027). Monospecific anti-a serum was
kindly supplied by Dr P. V. Holland. Subtyping of
HB Ag in the available sera was carried out by the
TEOP method.
Because of the limited quantity of monospecific
anti-y serum, only 30 randomly chosen d- sera were
tested with it. HB Ag that was d- and y- was further
tested with anti-a serum.
RESULTS
The incidence of HB Ag among healthy subjects
and patients with liver diseases is shown in Table 1.
The clinical diagnosis of liver disease was supple-
mented by biochemical and histological examina-
tions of liver specimens obtained by biopsy or at
autopsy. Two of the hospitalized patients with non-
hepatic diseases (rheumatoid arthritis and carcinoma
of the stomach) were shown to be carriers of HB Ag.
The ages of patients at the onset of apparent or
inapparent hepatitis B virus infections in this com-
munity were investigated after classifying the serum
samples from the apparently healthy children in
3 age groups. No evidence of infection was noted
in those aged 6 months to 4 years, whereas 2 of
56 children in the 5-9-year age group and 1 of
73 individuals in the 10-14-year age group were
shown to be carrying HB Ag in their blood.
One antigen-positive patient with chronic aggres-
sive hepatitis was shown on histological evidence
to have active cirrhosis. Liver biopsies from an
antigen-positive fatal case revealed initially persistent
hepatitis, which progressed to cirrhosis with hepa-
toma during a follow-up period of 6 months. One
patient with an amoebic liver abscess and another
with extrahepatic portal obstruction were shown to
be carrying HB Ag. There was no evidence of cir-
rhosis in the liver biopsy specimen of the latter case.
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Table 2. Seasonal incidence of HB Ag-positive cases of acute hepatitis and tests for
significance a
Groups Period of observation Total no. of No. Percentagesera tested positive positive
A March-August 1972 (summer) 71 15 21
B September 1972-February 1973 (winter) 57 5 9
C March-August 1973 (summer) 71 14 20
D September 1 973-February 1974 (winter) 66 7 11
E summer, 1972 and 1973 142 29 20
F winter, 1972 and 1973 123 12 10
a Group A vs B: X2 3.7, p > 0.05; Group B vs C: X2 3.1, p > 0.05; Group C vs D: X2 2.2, p > 0.05;
Group E vs F: x2 5.7, p <0.05.
Seasonal incidence ofHB Ag-positive acute hepatitis HB Ag subtypes
When the HB Ag-positive cases were considered
according to seasons during the two years of investi-
gation (Table 2), it was noted that the proportion
of positive cases during the 2 summer seasons
(Group E) differed significantly at the 5% level
from that during the 2 winter seasons (Group F).
However, the proportions for individual seasons
were not significantly different from each other
(Table 2) and this might be due to an error in
sampling.
Seventy-three from a total of 89 HB Ag-positive
sera in the different groups were tested with mono-
specific anti-d serum (Table 3). In the group of
healthy carriers, the HB Ag detected in 19 of
29 sera (66 Y.) did not possess the d antigenic deter-
minants. Twelve d- sera tested in this group, how-
ever, contained HB Ag of Y subtype. In contrast,
HB Ag in 16 of 26 sera (62%) in the acute hepatitis
group were of D subtype, whereas 10 of 15 sera
(67%) in the chronic liver diseases group contained
Table 3. Subtypes of HB Ag among healthy carriers and patients with hepatic and
nonhepatic diseases in northern India
Subtypes
Source of serum samples sera typed D Y A
d+ d- y+ d-, y-
healthy carriers 29 10 19 (12)a 12
acute hepatitis 26 16 10 (8) 8 -
chronic liver diseases: 15 5 10 (10) 9 1
chronic aggressive hepatitis 3 1 2 (2) 2 -
cirrhosis 7 1 6 (6) 6
noncirrhotic portal fibrosis 2 2 - -
malignancy in the liver 3 1 2 (2) 1 1
other diseases b 3 2 1 - -
totals 73 33 40 (30) 29 1
a Figures in parentheses represent random samples tested with monospecific anti-y serum.
b These were amoebic liver abscess, extrahepatic portal obstruction, and rheumatoid arthritis.
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HB Ag of Y subtype. Only one serum with HB Ag
of A subtype was detected; this was from a patient
with a hepatoma. The serum from a patient in a
dialysis unit with acute hepatitis and renal failure
contained HB Ag of Y subtype. A healthy brother
of this patient living in the same family carried
HB Ag of the same serotype, whereas another
healthy brother in the same family had HB Ag
of D subtype in his serum.
DISCUSSION
The 2.3% incidence of healthy carriers of HB Ag
amongst adult male voluntary blood donors in
this geographic area is higher than that reported
for American, Danish, German, English, French,
and Swiss populations. The 0-0.1 % carrier rate
previously reported in India (10, 19) may have
been due to the smaller number of samples tested
or the techniques used. However, the results for
the groups of children (aged 6 months-14 years)
indicated that hepatitis B virus infections in this
community appeared only after the age of 4 years.
Children under the age of 4 years seem to be free
from this infection.
The association of hepatitis B virus infection
with acute hepatitis is less frequent in the present
study and in other reports from India (10, 19) than
in reports from the USA, England, and Sweden
(5, 9, 13, 22). The endemicity of hepatitis B virus
infection may be responsible for this lower frequency
of HB Ag in acute hepatitis in tropical countries,
such as India, where drug addiction is less common
and hepatitis caused by the hepatitis A virus or
other agents is probably more common. It is of
interest to note that the incidence of sporadic cases
of viral hepatitis type B at the present time is about
the same (12%Y) as it was in 1955-56 during the
water-borne Delhi epidemic of viral hepatitis
type A (15).
The significant increase in the incidence of HB
Ag-positive cases of acute hepatitis during the
2 summer periods of the present study a offers some
a Since submitting this paper for publication, we have
obtained a 24% incidence of HB Ag-positive cases of acute
hepatitis (16 positive of 68 sporadic cases studied) during
the period March-August 1974.
epidemiological evidence that the transmission of
hepatitis B virus during the summer months might
more frequently be by the urinary/faecal-oral route
(1, 7). In countries with poor hygienic conditions,
the activation and propagation of enteric organisms
are increased during the summer; in these environ-
ments, therefore, the urinary/faecal-oral route of
transmission may be more important than the paren-
teral one. The urinary/faecal routes of excretion
of virus could thus maintain a natural circulation
of hepatitis B virus in this community.
A relatively high proportion of patients with post-
necrotic cirrhosis (14 Y.) and noncirrhotic portal
fibrosis (13 %) was shown in this study to be asso-
ciated with type B viral hepatitis. Progressive changes
from viral hepatitis to cirrhosis, with or without
hepatoma, have been well documented, especially
in patients in whom the antigen persisted (12, 20, 22).
In the present study, these changes were observed
in two cases. The demonstration of HB Ag in
patients with rheumatoid arthritis, carcinoma of
the stomach, amoebic liver abscess, and extra-
hepatic portal obstruction suggests that the patho-
logical state of chronic carriers of HB Ag- might
be different.
A high incidence of HB Ag of Y subtype among
healthy persons in northern India and among patients
with chronic liver diseases was noted; in sporadic
acute hepatitis, however, the D subtype pre-
dominated.
A persistence of antigen occurred more com-
monly after mild or subclinical infection rather than
after the acute disease (2), and asymptomatic car-
riers, even with apparently normal liver function,
were shown histologically to have signs of chronic
liver disease (17). This evidence would explain how
the higher frequency of association between hepa-
titis B virus infection and cirrhosis might also be
due to the higher incidence of subclinical infections
or carrier states in this area, and why asymp-
tomatic carriers may frequently progress to cir-
rhosis. The similarity of subtypes of HB Ag among
the majority of healthy carriers and of patients with
chronic liver diseases in the present study and in
those by Nielsen & Le Bouvier (13) and Prince
et al. (18) might also be a pointer to this view.
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RtSUMP
INFECTION PAR LE VIRUS DE L'HEPATITE B EN INDE SEPTENTRIONALF:
PREVALENCE, SOUS-TYPES ET VARIATION SAISONNItRE
De mars 1972 a fevrier 1974, on a recherche en Inde
septentrionale l'incidence de l'infection par le virus de
l'hepatite B et les serotypes presents chez des porteurs
sains et chez des malades atteints d'affections hepatiques,
et 6tudi6 les variations saisonnieres de l'hepatite aigue
dans la region.
Des infections inapparentes par le virus de I'hepatite B
sont decel6es chez les enfants des I'age de 5 ans. La pro-
portion des porteurs de virus est de 2,3% chez les hommes
adultes en bonne sante et de 0,43% chez les femmes.
Chez des patients atteints d'hepatite aigue et chez d'autres
souffrant d'affections hepatiques chroniques, on compte
respectivement 15 et 19% de porteurs de I'antigene de
I'hepatite B (Ag HB). Dans le groupe des porteurs sains,
66% des serums positifs sont d-, mais la majorite
d'entre eux contiennent le d6terminant antigenique y.
Parmi les s6rums positifs obtenus chez des malades
atteints d'affections hepatiques chroniques, 67 % con-
tiennent un Ag HB de sous-type Y. Dans les cas d'hepa-
tite aigue, le sous-type D predomine. La similitude de
sous-type antigenique et de frequence plus elevee du
sous-type Y parmi les porteurs sains et les patients atteints
d'affections h6patiques chroniques semble indiquer que
la plupart des cas de cirrhose sont la consequence d'infec-
tions subcliniques. Dans la majorite des cas d'hepatite
aigue positifs, il y a elimination ult6rieure de l'antigene
du sang.
Parmi les hepatites aigues, le nombre de cas positifs
pour l'Ag HB a 6te significativement plus 6leve pendant
les mois d'6tW 1972 et 1973 que pendant les mois d'hiver.
Cela plaide en faveur d'une propagation plus intense du
virus par voie f6cale et urinaire ou son activation pendant
I'ete, specialement dans les pays a niveau d'hygiene
mediocre.
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